Dosagens séricas repetidas de enticonvulsivantes em pacientes epilépticas
暂无分享,去创建一个
[1] M. Brodie,et al. Antiepileptic Drug Monitoring at the Epilepsy Clinic: A Prospective Evaluation , 1991, Epilepsia.
[2] S. Wallace. Anti‐epileptic Drug Monitoring: an Overview , 1990, Developmental medicine and child neurology.
[3] G. Mwaluko,et al. Therapeutic drug monitoring (TDM): an aid to anti-epileptic drug (AED) therapy in Zimbabwe: a review. , 1990, East African Medical Journal.
[4] G. Porro,et al. Intractable epilepsies. An open trial with Clobazam. , 1989, Acta neurologica.
[5] C. Cornaggia,et al. Antiepileptic drug monitoring in severe epilepsies. , 1987, Acta neurologica.
[6] D. Lisk,et al. Drug compliance and seizure control in epileptic children. , 1985, Postgraduate medical journal.
[7] F. Schobben,et al. Continuous monitoring of plasma antiepileptic drug levels , 1983, Acta neurologica Scandinavica. Supplementum.
[8] G. Peterson,et al. Determinants of Patient Compliance with Anticonvulsant Therapy , 1982, Epilepsia.
[9] W. Pryse-Phillips,et al. Compliance with Drug Therapy by Epileptic Patients , 1982, Epilepsia.
[10] J. Penry,et al. Usefulness of blood levels of antiepileptic drugs. , 1974, Archives of neurology.
[11] J. Meijer. Knowledge, attitude and practice in antiepileptic drug monitoring. , 1991, Acta Neurologica Scandinavica, Supplementum.
[12] R. Lesser,et al. An overview of therapeutic drug monitoring principles. , 1984, Cleveland Clinic quarterly.
[13] G. Scollo-Lavizzari. Pharmacological principles in the long-term treatment of epilepsy. , 1981, European Neurology.
[14] E. Perucca,et al. Quality Control in Drug Measurement , 1980, Therapeutic drug monitoring.
[15] A. Baruzzi,et al. Indications of anticonvulsant plasma levels monitoring in medical and surgical treatment of epilepsy. , 1979, Journal of neurosurgical sciences.